Drug intelligence / Profile preview

Ginkgo-Maren

Development stage
Unknown
Lead developer
Krewel Meuselbach
Modality
Small Molecules
Administration
Oral
01

Overview

Ginkgo-Maren is an approved herbal medicinal product developed and marketed by the German pharmaceutical company Krewel Meuselbach. The active ingredient is a standardized dry extract derived from the leaves of *Ginkgo biloba*. It is primarily indicated for the symptomatic treatment of organic brain-related cognitive impairment and dementia-related syndromes, including symptoms such as memory loss, concentration difficulties, dizziness, tinnitus, and headaches. The extract's therapeutic effects are attributed to its complex mixture of active components, notably ginkgolides, bilobalide, and flavonoids. These constituents work synergistically to improve blood rheology, enhance cerebral and peripheral blood flow, and provide neuroprotective effects by scavenging free radicals and antagonizing platelet-activating factor (PAF) receptors. In Germany, it is available as a pharmacy-only, non-prescription medication in various strengths and formulations, including film-coated tablets and oral solutions.

Brand names
Ginkgo-Maren
Other names
Ginkgo biloba leaf dry extractGinkgo-biloba-Blätter-Trockenextrakt
02

Targets

PTAFR (Platelet-activating factor receptor)

Beyond the preview

Go deeper on Ginkgo-Maren.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ginkgo-Maren.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call